Age-related macular degeneration: epidemiology and optimal treatment

Medicin og biovidenskab

• Blindness 24%
• Choroidal Neovascularization 69%
• Developed Countries 7%
• Disease Progression 6%
• Elderly 5%
• Epidemiology 75%
• Eye 19%
• Fluorescein 8%
• Fluorescein Angiography 9%
• Fluorescence 6%
• Genetic Predisposition to Disease 8%
• Geographic Atrophy 47%
• Incidence 7%
• Lasers 19%
• Light Coagulation 28%
• Macular Degeneration 100%
• Ocular Vision 6%
• Photochemotherapy 17%
• Physicians 5%
• Population 6%
• Smoking 5%
• Therapeutics 15%
• Verteporfin 11%
• Visual Acuity 13%
• Western World 9%